Shinichi Kawashima, Motoko Kawashima & Kazuo Tsubota Vitreoretinal surgery has recently undergone remarkable developments. The introduction of micro-incision vitrectomy surgery using 25- and 23-gauge techniques has led to minimally invasive, faster, safer, and more accurate surgeries. Similarly, intraocular illumination and observation systems have advanced from light pipes to chandelier illumination, slit illumination, wide-angle viewing systems, and intraocular endoscopes. Compared to observation via the cornea and optic media, vitreous surgery using an endoscope is extremely useful, as the endoscope is inserted directly into the eye, circumventing the difficulties of corneal clouding and small pupil diameters. Furthermore, there are no blind spots after surgery. We here discuss the advantages of intraocular endoscope use, the current state of endoscopy-guided vitreoretinal surgery, and its future prospects.Keywords:: endoscopyeyemicro-incision vitrectomy surgerytechniquevitrectomy

Vitreous involvement as a result of penetrating trauma complicates and worsens the prognosis in retinal detachment repair. Seven patients in whom poor visualization of the fundus seemed to preclude success by routine procedures underwent combined vitrectomy, scleral buckling, release of subretinal fluid, and intravitreal gas injection. chandelier taman seputehThe retina was successfully reattached in five of the seven patients, although postoperative visual acuity was limited - possible on account of the duration of retinal detachment prior to repair or because of the degree of macular involvement. arctic pear chandelier round 60cmContinue reading full articlechandelier only fools and horses episode This PDF is available to Subscribers Only

June 2016, Volume 4, Issue 2, pp 75–83Surgical Management of Tractional Retinal Detachments in Proliferative Diabetic RetinopathyDiabetic Retinopathy: Medical and Surgical Therapies (Jorge Fortun, Section Editor)First Online: 14 March 2016DOI: 10.1007/s40135-016-0096-xCite this article as: Khatib, N. & Carvounis, P.E. Curr Ophthalmol Rep (2016) 4: 75. Part of the following topical collections:Diabetic Retinopathy: Medical and Surgical TherapiesAbstractThere have been significant recent advances in the management of diabetic tractional retinal detachments. Pre-operative intravitreal bevacizumab causes regression of active vessels and less intraoperative hemorrhage, small-gauge vitrectomy has dramatically changed how segmentation and delamination are performed, and bimanual surgery and viscodissection offer additional options. Intraoperative bevacizumab may decrease the incidence of postoperative vitreous hemorrhage. Single surgery success rates are generally >85 % with final anatomic success rates approaching 100 %.

Useful vision (VA ≥ 20/100) is attained in <40 % of patients in most series while ambulatory vision (VA ≥ 5/200) is attained in <80 % patients in most series. No light perception/light perception only vision occurs in <10 % patients while recurrent hemorrhage occurs in approximately one-third of patients. Laser - Illumination - Fiber Optics Probes › FCI Fiber Optic Probes › FCI Fiber Optic Probes FCI fiber optic probes are the price-conscious alternative. The probes are compatible with all vitrectomy-systems including theThe probes are available in 20/23/25 gauge in a focus, wide angle and chandelier version. The highest quality at a For an overview of the FCI Fiber Optic Probes clickOur Products  Vitreoretinal Surgery  Microsurgical Systems  Stellaris PC The Stellaris PC platform provides a high-performance, feature-rich, combined experience that leverages Bausch + Lomb’s legacy of vitreoretinal surgical innovation with the demonstrated excellence of the Stellaris phacoemulsification platform.

The Stellaris PC allows surgeons to have true “procedural choice” by providing the most advanced technology for both vitreoretinal and cataract surgery in a single system. It is a versatile system that allows surgeons the flexibility to perform different ophthalmic procedures while saving time, space and money for the surgeons and the patients they serve. Please note: The Stellaris PC replaces the MillenniumMicrosurgical System. Benefits to surgeons and their patients: It is the only vitreoretinal surgical system that comes with a dual light source and surgeon-selected color filters that allow for differentiated viewing designed to enhance the surgeon’s ability to see ocular tissue better under various surgical conditions. It allows surgeons a platform for the smallest incisions for both retinal and cataract surgeries. It is capable of 1.8 mm MICS phacoemulsification as well as a complement with Bausch + Lomb's existing proprietary 25-gauge system of instruments for retinal surgery, along with standard 23- and 20-gauge instruments.

It has light-weight, ultrahigh-speed vitrectomy probes for conventional and transconjunctival vitrectomy (TSV). Stellaris Meets the Needs of Surgeons Dr. Carl Awh, a long-time advisor to Bausch + Lomb and a private-practice physician with Tennessee Retina in Nashville, said, “The Stellaris PC meets the needs of today’s vitreoretinal and cataract surgeons. It allows us to perform the most advanced techniques with an intuitive, more compact system and is ideally equipped for both the ambulatory surgery center and the hospital operating room.”1.   Use Of Site. (the “Website”) is for informational and educational purposes only and is not intended as a substitute for professional medical help, advice, diagnosis, treatment or hands-on training experience. Providers who post information or instructional materials on the Website are not providing health care services through the use of this Website. Use of, or posting of information, images or educational materials on, the Website does not constitute establishment of a physician-patient or clinical relationship with any individual, nor establishment or offer to enter into a business relationship with any medical professional, institution or organization.

Any reliance on any information provided by the Website or individuals using the Website is solely at your own risk. Ophthalmic Edge, LLC is not liable for any adverse events which occur from use of the Website or as a result of any medical conditions you may have. Information on this Website should never replace the advice of a physician. IF YOU HAVE, OR ARE HAVING, A MEDICAL EMERGENCY, YOU SHOULD CONTACT YOUR PHYSICIAN OR LOCAL EMERGENCY NOTIFICATION SYSTEM, OR GO TO YOUR LOCAL EMERGENCY ROOM. Your use of this Website is acceptance of these Terms of Use and represents the same effect as physically signing an agreement. We have the right to amend these Terms of Use at any time without notice to you by posting the revised Terms of Use on the Website. You agree that you are bound by those changes by continuing to use the WebsiteWe do not warrant, and are not liable for, the accuracy, completeness, timeliness or usefulness of information, opinions, services or other information provided through the Website or on the Internet generally.

We shall not independently review or verify the accuracy or completeness of the information shared on the Website. We retain the right to, and shall, remove any posts that we consider inflammatory, inappropriate or inconsistent with Website policies. This site may include links to other sites that are not owned by or under our control and we are not responsible for, and make no representations, warranties or recommendations with respect to the usefulness, availability or content of any such sources, and you assume all responsibility with respect to the use of such sites and any and all information or services furnished through such sites. Furthermore, the information, opinions, and advice (if any) in articles posted on, or linked to, this website are solely those of the author. The information on the Website may be changed periodically without prior notice. All content on the Website is provided "as is." Use of such information is voluntary, and reliance on it should only be undertaken after an independent review of its accuracy, completeness, efficacy, and timeliness.

Your sole and exclusive remedy for dissatisfaction with the Website is to stop using the Website. 3.   Adverse Technical Events.   All information is transmitted over a medium which is beyond our control and jurisdiction. Accordingly, we assume no responsibility for, or relating to, delay, failure, interruption or corruption of any data or other information transmitted in connection with use of this Website or sites accessed through this site. 4.   Limitation Of Liability.   TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT WILL WE BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES ARISING OUT OF THE USE OF OR INABILITY TO ACCESS THE WEBSITE, INCLUDING, WITHOUT LIMITATION, DAMAGES FOR LOSS OF GOODWILL, WORK DISRUPTIONS, COMPUTER FAILURE OR MALFUNCTION, OR ANY AND ALL OTHER COMMERCIAL DAMAGES OR LOSSES, EVEN IF ADVISED OF THE POSSIBILITY THEREOF, AND REGARDLESS OF THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT, BREACH OF WARRANTY OR OTHERWISE) UPON WHICH THE CLAIM IS BASED.

WE ARE NOT RESPONSIBLE FOR ANY LIABILITY ARISING OUT OF THE USE OF THIS WEBSITE AND/OR ANY MATERIAL LINKED THROUGH THE WEBSITE. 5.   Copyright and Trademarks.   All content included on the Website including, but not limited to, text, photographs, video, documents, graphics, button icons, images, artwork, names, logos, trademarks, service marks and data (the "Content"), in any form including the compilation thereof, are proprietary to Ophthalmic Edge, LLC and protected by U.S. and international copyright law and conventions. The Content includes both Content owned or controlled by Ophthalmic Edge, LLC and Content owned or controlled by third parties and licensed to Ophthalmic Edge, LLC. Except as set forth below, direct or indirect reproduction of the Content, in whole or in part, by any means, is prohibited without our express written consent. You are authorized only to use the Website for personal use and are not authorized to reproduce, sell or exploit the Website or content of the Website for commercial purposes.

You may link your site to the Website, however, Ophthalmic Edge, LLC does not wish to be linked to or from any third-party website or link which contains (1) any information that misrepresents the nature of your relationship with Ophthalmic Edge, LLC, or incorrect facts or data about Ophthalmic Edge, LLC; (2) any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, or indecent information of any kind, (3) any information or other material which violates or infringes upon the rights of others.You agree to indemnify and hold harmless Ophthalmic Edge, LLC and its officers, directors, employees, agents, developers, vendors, affiliates, third party information providers, licensors and others involved in the development or the delivery of products, services or information over the Website, from and against any and all liabilities, expenses, damages and costs, including reasonable attorneys’ fees, arising from any violation by you of these Terms of Use or your use of the Website or any products